Comparative Efficacy and Safety of Oral Labetalol and Nifedipine in the Management of Preeclampsia: A Randomized Controlled Trial
DOI:
https://doi.org/10.55489/ijmr.1202202455Keywords:
Preeclampsia, Labetalol, Nifedipine, Antihypertensive therapy, Blood pressure control, Fetomaternal outcomesAbstract
Background: Preeclampsia, a major cause of maternal and perinatal morbidity, requires effective antihypertensive therapy to control blood pressure, prolong pregnancy, and reduce complications. Labetalol and Nifedipine are commonly used, but their comparative efficacy and safety remain under evaluation.
Objective: To compare the efficacy and safety of oral Labetalol and Nifedipine in managing preeclampsia, focusing on blood pressure control, pregnancy prolongation, prevention of convulsions, and fetomaternal outcomes.
Methods: In this prospective, open-label, randomized controlled trial, 136 antenatal women with preeclampsia (blood pressure ≥140/90 mmHg with proteinuria) were randomized to receive Labetalol (100 mg twice daily, n=68) or Nifedipine (10 mg thrice daily, n=68) at Dhiraj General Hospital, India, from January 2020 to July 2021. Doses were titrated to achieve blood pressure ≤140/90 mmHg. Outcomes included blood pressure reduction, time to delivery, maternal side effects, complications, mode of delivery, and neonatal outcomes. Statistical analyses included t-tests, chi-square tests, and Kaplan-Meier survival analysis.
Results: Nifedipine achieved greater reductions in systolic (121.3 vs. 126.2 mmHg, p=0.048) and diastolic blood pressure (84.3 vs. 87.4 mmHg, p=0.014) compared to Labetalol, with medium effect sizes (Cohen’s d=0.40-0.50). Nifedipine was associated with higher tachycardia (27.9% vs. 5.9%, p=0.003) and cesarean rates (44.1% vs. 26.5%, p=0.059). No significant differences were observed in pregnancy prolongation, proteinuria, or neonatal outcomes (birth weight, stillbirth, NICU admissions; p>0.05).
Conclusion: Nifedipine offers superior blood pressure control but higher tachycardia risk, while Labetalol is safer for patients prone to tachycardia. Both drugs yield comparable fetomaternal outcomes.
References
1. Pre-eclampsia. Alabama perinatal excellence collaborative guidelines. Protocol; 2014. Classification of Hypertensive Disorders. ACOG 2013;2:13-5.
2. Williams obstetrics 23rd edition;34th chapter - In pregnancy hypertension:706- 709.
3. Preeclampsia: Hypertension in pregnancy report of the american college of obstetricians and gynecologists' task force on hypertension in pregnancy. ACOG 2013;122:1122-31.
4. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Pregnancy Hypertension. Text Book of Williams Obstetrics. 23rd Edition.2010 New York, McGraw Hill. 706-757 pp.
5. Fernando Arias, Shirish Daftary, Amarnath Bhide, "Practical guide to high risk pregnancy and delivery" 3 rd edition 2007.
6. Khan KS, Wojdyla D, Say L, Gülmezoglu A. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-1074. DOI: https://doi.org/10.1016/S0140-6736(06)68397-9 PMid:16581405
7. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, et al. Am J Obstet Gynecol. 2006 Apr; 194(4):921-931. DOI: https://doi.org/10.1016/j.ajog.2005.10.813 PMid:16580277
8. Berg CJ, Chang J, Callaghan WM, Whitehead SJ. ObstetGynecol 2003;101(2):289-296. DOI: https://doi.org/10.1097/00006250-200302000-00015 PMid:12576252
9. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2000;2003(4):CD002863. doi: 10.1002/14651858.CD002863. Update in: Cochrane Database Syst Rev. 2003;(3):CD002863. DOI: https://doi.org/10.1002/14651858.CD002863 PMCid:PMC8456320
10. Goodman & Gilman's the pharmacological basis of therapeutics- 11thed.(2006):32.
11. Rezaei Z, Rahimi FS, Pourmojieb M, Youefzadeh-Fard Y, Motevalian M, et al. Acta Medica Iranica 2011; 49: 701-705.
12. Ray JG, Vermeculen M, Burrows E, Burrows R. Use of antihypertensive medication in pregnancy and the risk of adverse perinatal outcomes: McMaster outcome study of hypertension in pregnancy 2 (MOS HIP 2). BMC Pregnancy Childbirth. 2001;1:6-14. DOI: https://doi.org/10.1186/1471-2393-1-6 PMid:11737873 PMCid:PMC60658
13. Nakhai-Pour HR, Rey E, Berard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformation or small-forgestational-age newborns. Birth Defects Res B Dev ReprodToxicol. 2010;89(2):147-154. DOI: https://doi.org/10.1002/bdrb.20238 PMid:20437474
14. Nita K Patel, Mansi Gadhavi, Dhaval Gorasia, Manish R Pandya. Comparative evaluation of antihypertensive drugs in the management of pregnancy-induced hypertension. Int J Basic Clin Pharmacol2012;1:174-177. DOI: https://doi.org/10.5455/2319-2003.ijbcp003412
15. Dalal N, Bhattacharjee S, Tiwari M. A comparative study of oral labetalol versus oral nifedipine in hypertensive disorders of pregnancy. International Journal of Clinical Obstetrics and Gynaecology. 2019;3(3):132-136. DOI: https://doi.org/10.33545/gynae.2019.v3.i3c.21
16. Thakur V, Thakur A, Saroshe S. Comparison of effect of nifedipine, labetalol and methyldopa in treatment of hypertension in pregnancy in a tertiary care government hospital. Int J Reprod Contracept Obstet Gynecol. 2016;5(1):17-22. DOI: https://doi.org/10.18203/2320-1770.ijrcog20151495
17. Deshmukh UB, Savitha A, Tengli S. Comparative study of labetalol and nifedipine in management of hypertensive disorders of pregnancy in BRIMS tertiary care center. The New Indian Journal of OBGYN. 2021;8(1):117-120. DOI: https://doi.org/10.21276/obgyn.2021.8.1.22
18. Shekhar S, Sharma C, Thakur S, Verma S. Oral Nifedipine or Intravenous Labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstetrics &Gynecology. 2013;122(5):1057-1063. DOI: https://doi.org/10.1097/AOG.0b013e3182a9ea68 PMid:24104790
19. Hangarga US, Rita D, Harshitha K. Comparative study of labetalol and nifedipine in management of hypertensive disorders in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6(1):194-197. DOI: https://doi.org/10.18203/2320-1770.ijrcog20164656
20. Sachdeva PD, Patel BG, Bhatt MV. A study of incidence and management of pregnancy induced hypertension in Central Gujrat, India. International Journal of Universal Pharmacy and Life Sciences. 2011;1(3):61-70.
21. Dhali B, Bhattacharya S, Ganguly RP, Bandyopadhyay S, Mondal M, Dutta M, et al. A randomized trial of intravenous labetalol & oral nifedipine in severe pregnancy induced hypertension. Int J Reprod Contracept Obstet Gynecol. 2016;1(1):42-46. DOI: https://doi.org/10.5455/2320-1770.ijrcog001912
22. Scardo JA, Vermillion ST, Hogg BB, Newman RB. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. American journal of obstetrics and gynecology. 1996;175(2):336-340. DOI: https://doi.org/10.1016/S0002-9378(96)70143-6 PMid:8765250
23. Elatrous S, Nouira S, Besbes LO, Marghli S, Boussarssar M, Sakkouhi M, et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive care medicine. 2002;28(9):1281-1286. DOI: https://doi.org/10.1007/s00134-002-1406-3 PMid:12209278
24. Vermillion ST, Scardo JA, Newmann RB, Chauhan SP. A randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies of pregnancy. Am J ObstetGynaecol. 1999;181(4):858-861. DOI: https://doi.org/10.1016/S0002-9378(99)70314-5 PMid:10521742
25. Raheem I, Saaid R, Omar S, Tan P. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: A randomised trial. BJOG. 2012;119(1):78-85. DOI: https://doi.org/10.1111/j.1471-0528.2011.03151.x PMid:21985500
26. Thakur V, Thakur A, Saroshe S. Comparison of effect of nifedipine, labetalol and methyldopa in treatment of hypertension in pregnancy in a tertiary care government hospital. Int J Reprod Contracept Obstet Gynecol . 2016;5(1):17- 22. DOI: https://doi.org/10.18203/2320-1770.ijrcog20151495
27. Wilkerson RG, Ogunbodede AC. Hypertensive Disorders of Pregnancy. Emerg Med Clin North Am. 2019 May;37(2):301-316. DOI: https://doi.org/10.1016/j.emc.2019.01.008 PMid:30940374
28. Giannubilo SR, Bezzeccheri V, Cecchi S, Landi B, Battistoni GI, Vitali P, et al. Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy. Arch Gynecol Obstet. 2012; 286(3):637- 42. DOI: https://doi.org/10.1007/s00404-012-2371-x PMid:22581388
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Prarthana Jhaveri, Dhrumil Shah, Kishor Chauhan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
